A Study Evaluating the Efficacy and Safety of Vismodegib (GDC-0449) in Operable Basal Cell Carcinoma

Clinical trial NCT01201915 · COMPLETED

Trial details

NCT number: NCT01201915
Sponsor: Genentech, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Basal Cell Carcinoma

Start date: 2010-10-01
Primary completion: 2013-05-01
Enrollment: 74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.